| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824875 | Clinical Therapeutics | 2014 | 10 Pages |
Abstract
The efficacy and tolerability of AML/LOS 5/100 mg/d was found to have been noninferior to those of LOS/HCTZ 100/12.5 mg/d in these hypertensive patients nonresponsive to losartan 100-mg/d monotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Soon Yong MD, PhD, Taehoon MD, PhD, Jang-Ho MD, PhD, Do-Sun MD, PhD, Seoung Uk MD, PhD, Young Kwon MD, PhD, Min Su MD, PhD, Won Ho MD, PhD, Kyoo Rok MD, PhD, Hoon Ki MD,